5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
CAS: 183208-34-6
Rif. 3D-FB42029
1g | Fuori produzione | ||
2g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- 5-Bromo-7-Aza-Indolin-2(3h)-One
- 2H-Pyrrolo[2,3-b]pyridin-2-one, 5-bromo-1,3-dihydro-
- 5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
- 5-bromo-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-one
5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one is a cancer drug that is a potent inhibitor of angiogenesis. This compound has been shown to inhibit tumor growth in vitro and in vivo. 5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one also shows antiangiogenic activity in mouse models of cancer. The antitumor effects of this drug are mediated by inhibition of the protein tyrosine kinases VEGF receptor 1 (VEGFR1) and VEGFR2. Sunitinib is an oral anticancer agent used for the treatment of metastatic renal cell carcinoma and other solid tumors. It has been found to be active against a variety of human cancers including melanomas, lung cancers, breast